MabPlex
PrivateLast Round
Series B
Jun 8, 2020
Total Funding Raised
$129.8M
Company Overview
MabPlex operates in Healthcare & Life Sciences and is based in Yantai. Its latest recorded funding round was a Series B round in June 2020.
MabPlex is a biopharmaceutical company that provides comprehensive contract development and manufacturing services, ranging from drug development to the production of monoclonal antibodies, recombinant proteins, antibody-drug conjugates, and bispecifics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MabPlex Comparables
Compare MabPlex with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BiBo Biopharma Engineering Co., Ltd. | 88% | |
| Abzena | 87% | |
| WuXi Biologics | 86% |
For institutional investors. Book with your work email.
MabPlex Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 8, 2020 | ||||
| Series A | Jan 17, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
MabPlex Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Qiandao Fund | Series B |
| China Merchants Securities (HK) Co., Limited | Series B |
| National Fund for Technology Transfer and Commercialisation | Series A |
| China Merchants Securities | Series B |
| DT Capital Partners | Series B |
| OrbiMed | Series B |
| Huajin Capital | Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 8, 2020
$71M round led by Huajin Capital.
For institutional investors. Book with your work email.
MabPlex Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about MabPlex's valuation, stock price, and market status.
Is MabPlex a public or private company?
MabPlex is a private company.
What is the current stock price of MabPlex?
MabPlex is a private company, so its shares have no public market price. Caplight tracks MabPlex's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is MabPlex worth (valuation)?
Valuation information for MabPlex is not publicly available.
Can I buy MabPlex stock?
MabPlex shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was MabPlex's last funding round?
MabPlex's most recent funding round was Series B on June 8, 2020.
Who are the main investors in MabPlex?
Key investors in MabPlex include National Fund for Technology Transfer and Commercialisation, Huajin Capital, SDIC Venture Capital, State Development and Investment Group Co., Ltd., Shenzhen Capital Group.
Will MabPlex IPO soon?
No public IPO plans have been announced for MabPlex.
How can I track MabPlex secondary market activity?
Caplight tracks bids, offers, and trades in MabPlex's shares on secondary markets.